# Reproductive System & OBGYN

## Urogenital Embryonic Origins

|Primordial|Female|Male|
|-|-|-|
|Gubernaculum|Ovarian & Round ligament|-|
|Processus vaginalis|-|Tunica vaginalis|
|Indifferent gonad|Ovary|Testis|
||Theca cell|Leydig cell|
||Granulosa cell|Sertoli cell|
|Mesoderm|Paramesonephric duct|Mesonephric duct|
||Mullerian duct|Wolffian duct|
|Mullerian & Wolffian duct|Frimbriae|Epididymis|
||Fallopian tube|Vas deferens|
||Uterus|Seminal vesicle|
||Upper vagina|Ejaculatory duct|
|Urogenital sinus|Lower vagina|Prostatic utricle|
||Paraurethral gland of Skene|Prostate gland|
||Greater vestibular gland of Bartholin|Bulbourethral gland of Cowper|
|Urogenital fold|Mons pubis|Dorsal penile shaft|
||Labia minora|Ventral penile shaft|
|Labioscrotal swelling|Labia majora|Scrotum|
|Genital tubercle|Clitoris|Penis|

## Ligaments of Uterus and Ovary

|Ligament|Connects|Contents|
|-|-|-|
|Broad ligament|Uterus ~ Pelvis :: lateral|-|
|Round ligament|Uterus ~ Labia majora|Gubernaculum|
|Ovarian ligament|Uterus ~ Ovary|Gubernaculum|
|Infundibulopelvic [Suspensory] ligament|Ovary ~ Pelvis :: lateral|Ovarian vessels|
|Pubocervical ligament|Cervix ~ Pubis|-|
|Cardinal ligament|Cervix ~ Pelvis :: lateral|Uterine vessels|
|Uterosacral ligament|Cervix ~ Sacrum|Inferior hypogastric plexus|

![](../Figures/Ligaments%20of%20Uterus%20and%20Ovary.png)

## Sexual Development

|Female|Male|
|-|-|
|Thelarche|Gonadarche|
|Pubarche|Pubarche|
|Growth spurt|Adrenarche|
|Menarche|Growth spurt|

## Sex Hormone Production

|Hormones|Regulation|Female|Male|
|-|-|-|-|
|Progesterone<br>DHEA<br>Androstenedione<br>Testosterone|ACTH|Adrenal gland|Adrenal gland|
|Progesterone|LH<br>FSH|Corpus luteum|Testis|
|Testosterone|LH|Theca cells<br>Corpus luteum|Leydig cells|
|Anti-Mullerian hormone (AMH)<br>Estradiol<br>Inhibin|FSH|Granulosa cells<br>Corpus luteum|Sertoli cells|
|Estrone|-|Adipose cells|Adipose cells|
|Dihydrotestosterone (DHT)|-|Peripheral cells|Peripheral cells|

## Estrogens in Females

|Hormone|Precursor|Precursor Site|Enzyme|Enzyme Site|Timing|
|-|-|-|-|-|-|
|Estrone|Androstenedione|Adrenal gland|Aromatase|Adipose cells|Post-menopause|
|Estradiol|Testosterone|Theca cells|Aromatase|Granulosa cells|Non-pregnancy|
|Estriol|DHEA sulfate (DHEAS)|Adrenal gland|Sulfatase|Placenta|Pregnancy|

## Incresed Exposure to Estrogen

- Nulliparity
- Early menarche
- Late menopause

## Hormone Changes During Pregnancy

|Item|Hormones|Sources|
|-|-|-|
|W|Human chorionic gonadotropin (hCG)|Placenta|
||17-Hydroxyprogesterone|Corpus luteum|
|X|Human placental lactogen (hPL)|Placenta|
||Progesterone|Corpus luteum<br>Placenta|
|Y|Corticotropin-releasing hormone (CRH)|Placenta|

![](../Figures/Hormone%20Change%20During%20Pregnancy.png)

## Prenatal Care

|GA (weeks)|Testing|
|-|-|
|3 ~ 4|Pregnancy test|
|4 ~ 5|hCG 1000 ~ 1500 mIU/mL<br>Gestational sac|
|10 ~ 12|PAPP-A<br>Nuchal translucency<br>± Chorionic villus sampling (CVS)|
|16 ~ 20|Quad screening<br>± Amniocentesis|
|20 ~ 24|Level II ultrasonagraphy|
|24 ~ 28|100-g OGTT|
|26 ~ 28|± RhoGAM|
|28 ~ 32|± Steroids|
|35 ~ 37|GBS culture|

## Causes of Size/Date Discrepancy

- Inaccurate dating
- Molar pregnancy
- Multiple gestation
- Macrosomia
- Hydramnios
- Obesity
- Distended bladder
- Adnexal mass

## Quad Screening {HAEI}

- hCG
- AFP
- Estriol
- Inhibin A

## Etiology of Abnormal hCG Trending

- Abortion
- Ectopic pregnancy
- Trophoblastic diseases (GTD)
  - Hydatidiform moles
  - Germ cell tumors (GCT)
- Aneuploidy

## Etiology of Elevated AFP

- Inaccurate dating
-  Germ cell tumors (GCT)
  - Endodermal sinus tumor (EST)
  - Embryonal carcinoma
  - Teratoma
- Neural tube defects :: open
  - Anencephaly
  - Encephalocele
  - Spina bifida aperta
    - Meningocele
    - Myelomeningocele
- Abdominal wall defects
  - Gastroschisis
  - Omphalocele
- Fetal demise
- Multiple gestation
- Placental abruption

## Etiology of Reduced AFP

- Inaccurate dating
- Trisomy 21 & 18
- Fetal demise

## Fetal Biometric Parameters on Ultrasound

- Crown-rump length (CRL)
- Biparietal diameter (BPD)
- Head circumference (HC)
- Abdominal circumference (AC)
- Femur length (FL)

## Classification of Pregnancy Loss

- Spontaneous abortion: < 20 weeks / < 500 g
- Intrauterine fetal demise (IUFD): > 20 weeks / > 500 g

## Spontaneous Abortion

|Type|Bleeding|POC Expulsion|Cervical Os|POC Presence|FCA|Management|
|-|-|-|-|-|-|-|
|Threatened|+|-|Closed|+|+|Pelvic rest|
|Inevitable|+|-|Open|+|+|Expectant / Medical / Surgical|
|Incomplete|+|+|Open|+|-|Expectant / Medical / Surgical|
|Missed|-|-|Closed|+|-|Expectant / Medical / Surgical|
|Complete|+|+|Closed|-|-|-|

- Product of conception (POC)
- Fetal cardiac activity (FCA)

## Management of Irreversible Spontaneous Abortion

- Expectant management
- Medical evacuation: Mifepristone [RU486] & Misoprostol
- Surgical evacuation
  - Manual uterine aspiration (MUA): < 12 weeks
  - Dilatation and curettage (D&C): > 12 weeks

## Management of Intrauterine Fetal Demise (IUFD)

- Dilatation and curettage (D&C): < 24 weeks
- Labor induction: > 24 weeks / autopsy

## Management of Induced Abortion

### First Trimester

- Medical abortion
  - Misoprostol & Mifepristone
  - Misoprostol & Methotrexate
  - Misoprostol
- Manual uterine aspiration (MUA)

### Second Trimester

- Labor induction
- Dilatation and curettage (D&C)

## Hydatidiform Moles

||Complete Mole|Partial Mole|
|-|-|-|
|Karyotype|46,XX / 46,XY|69,XXX / 69,XXY / 69,XYY|
|hCG|↑↑↑↑|↑|
|Uterine Size|↑|-|
|Convert to Choriocarcinoma|2%|Rare|
|Fetal Parts|-|+|
|Components|2 sperms & 0 egg|2 sperms & 1 egg|

## Presentation of Preeclampsia

### Mild Preeclampsia

- BP > 140/90 mmHg
- Proteinuria :: dipstick ≥ 1+ / urine protein > 0.3 g/d

### Severe Preeclampsia

- BP > 160/110 mmHg
- Epigastric pain
- Liver enzymes ↑
- Proteinuria :: urine protein > 5.0 g/d
- Creatinine > 1.1 mg/dL
- Edema
- Headache
- Visual disturbances
- Thrombocytopenia :: platelet count ≤ 100,000/µL
- Disseminated intravascular coagulation (DIC)

### HELLP Syndrome

- Hemolysis :: intravascular
- Elevated liver enzymes
- Low platelet count

## Indications of Intrapartum Prophylaxis Against GBS

- Fever
- History of GBS-affected neonates
- Preterm labor
- Rupture of membranes > 18 hours
- Urine culture
- Vaginal culture

## Fetal Heart Rate (FHR)

|Finding|Definition|Significance|
|-|-|-|
|Acceleration|↑ 15/min for 15 seconds ~ 2 minutes|Reassuring|
|Early deceleration|↓ during a uterine contraction<br>Onset to nadir > 30 seconds<br>|Head compression|
|Late deceleration|↓ after a uterine contraction<br>Onset to nadir > 30 seconds|Uteroplacental insufficiency|
|Variable deceleration|↓ 15/min for 15 seconds ~ 2 minutes<br>Onset to nadir < 30 seconds|Cord compression|

## Fetal Heart Rate (FHR) Category III

- Bradycardia
- Recurrent late deceleration
- Recurrent variable deceleration
- Sinosoidal pattern

## Treatment of Late Decelerations {STOP}

- Sterile vaginal exam
- Tocolysis
- Oxygen
- Position :: left lateral recumbent

## Biophysical Profile (BPP)

- Nonstress test (NST): > 2 accelerations in 20 minutes
- Amniotic fluid volume: AFI > 5 cm / the deepest vertical pool > 2 cm
- Fetal breathing movements: breathing of > 30 seconds in 30 minutes
- Fetal movements: > 3 movements in 30 minutes
- Fetal tone: extension & flexion in 30 minutes

## Amniotic Fluid Index (AFI)

- Oligohydramnios: AFI < 5 cm / the deepest vertical pool < 2 cm
- Normal: AFI 5 ~ 25 cm
- Polyhydramnios: AFI > 25 cm

## Sterile Speculum Exam

- Pooling
- Valsalva
- Ferning
- Nitrazine

## Medications for Labor Induction

|Mechanism|Medication|
|-|-|
|PGE1 agonists|Misoprostol|

## Medications for Tocolysis

|Mechanism|Medication|
|-|-|
|β<sub>2</sub> agonists|Terbutaline<br>Ritodrine|
|COX inhibitors|Indomethacin|
|Ca channel blockers|Nifedipine|
|MgSO<sub>4</sub>|MgSO<sub>4</sub>|
|NO donors|Glyceryl trinitrate|
|Oxytocin antagonists|Atosiban|

## Stages of Labor

|Stage|Phase|Mom & Fetus|Primipara|Multipara|
|-|-|-|-|-|
|1|Latent|Effacement & Dilation: 0 → 6 cm<br>Engagement & Descent: high → 0|< 20 hours|< 14 hours|
||Active|Dilation: 6 → 10 cm<br>Descent: 0 → +2|> 0.7 cm/h|> 1 cm/h|
|2|-|Expulsion :: fetus|< 2 hours<br>< 3 hours if epidural|< 1 hours<br>< 2 hours if epidural|
|3|-|Expulsion :: umbilical cord & placenta|< 30 minutes|< 30 minutes|

## Factors Affecting the Duration of Labor {3P}

- Passenger
- Pelvis
- Power

### Passenger

- Attitude: flexed & neutral & extended
- Lie: longitudinal & oblique & transverse
- Presentation
  - Cephalic: vertex [occiput] & sinciput & brow & face & chin
  - Breech: complete & incomplete [footling] & frank
  - Shoulder: arm & shoulder & trunk
- Positions
  - Anterior: right anterior & anterior & left anterior
  - Transverse: right transverse & left transverse
  - Posterior: right posterior & posterior & left posterior

### Pelvis

|Class|Shape|Ischial Spines|Favored Positions|
|-|-|-|-|
|Gynecoid|Round|Non-prominent|All|
|Android|Heart|Prominent|None|
|Anthropoid|Vertical ellipse|Prominent|OA & OP|
|Platypelloid|Horizontal ellipse|Non-prominent|Tranverse|

![](../Figures/Pelvis%20Shapes.jpg)

## Bishop Score

- Position
- Consistency
- Effacement
- Dilation
- Station

![](../Figures/Bishop%20Score.png)

## Classification of Perineal Lacerations

|Degree|Depth|
|-|-|
|1|Submucosa|
|2|Perineal body|
|3|Anal sphincter|
|4|Rectal mucosa|

## Indications for Cesarean Delivery

- Cephalopelvic disproportion
- Non-reassuring fetal status
- Malpresentation
- Cord prolapse
- Abnormal placentation
  - Placenta accreta
  - Placenta previa
  - Vasa previa
- Uterine rupture
- Prior uterine surgery
- Cervical cancer

## Etiology of Postpartum Hemorrhage (PPH) {4T} {CARPIT}

|Mnemonic|Etiology|
|-|-|
|Thrombin|Coagulopathy|
|Tone|Atonic uterus|
|-|Ruptured uterus|
|Tissue|Plancental retention|
|-|Implantation site bleeding|
|Trauma|Trauma to the GU tract|

## Etiology of Abnormal Uterine Bleeding (AUB) {PALM-COEIN}

- Pregnancy
- Polyps
- Adenomyosis
- Leiomyoma
- Malignancy
- Coagulopathy
- Ovulatory dysfunction
- Endometrium
- Iatrogenic
- Not yet classified

## Classification of Amenorrhea

- Primary: no menarche by age 15 years
- Secondary: no menses for ≥ 3 cycles / ≥ 6 months

## Etiology of Primary Amenorrhea

|Etiology|Breast|Uterus|
|-|-|-|
|Outflow obstruction|+|+|
|Anorexia nervosa|+|+|
|Mullerian agenesis|+|-|
|Androgen insensitivity syndrome (AIS)|+|-|
|Constitutional growth delay|-|+|
|Turner syndrome|-|+|
|2° Hypogonadism|-|+|

## Etiology of Secondary Amenorrhea

|Etiology|GnRH|LH & FSH|SH|
|-|-|-|-|
|Pregnancy|↓|↓|↑|
|Polycystic ovary syndrome (PCOS)|↓|↓|↑|
|Menopause [Ovarian failure]|↑|↑|↓|
|Resistant ovary [Savage] syndrome|↑|↑|↓|
|2° Hypogonadism|↓|↓|↓|
|Asherman syndrome|-|-|-|
|Outflow obstruction|-|-|-|

## Presentation of Turner Syndrome

- Streak gonads
- Amenorrhea
- Webbed neck
- Shield chest
- Bicuspid aortic valve
- Coarctation of the aorta

## Indicators of Ovarian Reserve

|Indicator|Normal|
|-|-|
|FSH :: follicular phase|2 ~ 8|
|Anti-Mullerian hormone (AMH)|1 ~ 5|
|Antral follicle count (AFC)|5 ~ 10|

## Presentation of Menopause {HAVOCS}

- Hot flashes
- Atrophy of the vagina
- Osteoporosis
- Cardiovascular disease
- Sleep disturbances

## Treatment of Menopause

- Hormone replacement therapy (HRT)
- Topical estrogen
- SSRI & SNRI
- Calcium & Vitamin D supplements

## Rotterdam Criteria for Diagnosis of Polycystic Ovary Syndrome (PCOS)

- Anovulation
- Hyperandrogenism
- Polycystic ovaries

## Treatment of Polycystic Ovary Syndrome (PCOS)

- Ovulation induction
  - Estrogen modulators :: Clomiphene
  - Aromatase inhibitors
- Hormonal contraceptives
- Androgen antagonists
- 5α-Reductase inhibitors
- Metformin ± Statins
- Lifestyle modifications

## Non-surgical Treatment of Pelvic Organ Prolapse (POP)

- Kegel exercise
- Topical estrogen
- Pessary

## Pathogens of Genital Tract Infection

|Pathogen|Presentation|Treatment|
|-|-|-|
|Gardnerella vaginalis|Discharge :: grayish & fishy|Metronidazole|
|Neisseria gonorrhoea|Discharge :: greenish-yellow<br>Pelvic inflammatory disease (PID)|Ceftriaxone|
|Haemophilus ducreyi|Painful chancroid|-|
|Klebsiella granulomatis|Granuloma inguinale|Macrolides<br>Doxycycline|
|Treponema pallidum|Painless chancre<br>Condyloma lata|Penicillin|
|Chlamydia trachomatis|Discharge :: greenish-yellow<br>Lymphogranuloma venereum (LGV)<br>Pelvic inflammatory disease (PID)|Macrolides<br>Doxycycline|
|Candida albicans|Discharge :: white & curdy|Azoles|
|Trichomonas vaginalis|Discharge :: greenish-yellow & frothy|Metronidazole|
|HPV|Condyloma accumulata|-|
|HSV|Paniful ulcers|-|

## Reproductive Tumors

### Epithelial Tumors

- Serous cystadenoma<br>cystadenocarcinoma
- Mucinous cystadenoma<br>cystadenocarcinoma
- Endometrioid carcinoma
- Clear cell carcinoma
- Mixed cell carcinoma
- Transitional cell carcinoma [Brenner tumor]
- Carcinosarcoma [Malignant mixed Mullerian tumor (MMMT)]

### Stromal Tumors

|Female|Male|Markers|
|-|-|-|
|Theca cell tumor [Thecoma]|Leydig cell tumor|-|
|Granulosa cell tumor|Sertoli cell tumor|Inhibin|
|Fibroma|Fibroma|-|

### Germ Cell Tumors (GCT)

|Female|Male|Markers|
|-|-|-|
|Dysgerminoma|Seminoma|ALP & LDH|
|Choriocarcinoma|Choriocarcinoma|hCG|
|Endodermal sinus tumor (EST)|Endodermal sinus tumor (EST)|AFP|
|Embryonal carcinoma|Embryonal carcinoma|hCG & AFP|
|Teratoma|Teratoma|hCG & AFP|

## Triad of Meigs Syndrome

- Ovarian fibroma
- Pleural effusion
- Ascites

## Types of Endometrial Cancer

|Type|1|2|
|-|-|
|Histology|Endometrioid|Non-endometrioid|
|Risk factors|Estrogen|-|
|Prognosis|Favorable|Poor|

## Bethesda System for Pap Smear Results

- Squamous cell abnormalities
  - Atypical squamous cell (ASC)
  - Low-grade squamous intraepithelial lesion (LSIL)
  - High-grade squamous intraepithelial lesion (HSIL)
  - Squamous cell carcinoma
- Glandular cell abnormalities
  - Atypical glandular cell (AGC)
  - Adenocarcinoma in situ (AIS)
  - Adenocarcinoma

![](../Figures/Bethesda%20System%20for%20Pap%20Smear%20Results.jpg)

## Management of Abnormal Pap Smear Results

|Result|HPV|Age (years)|Management|
|-|-|-|-|
|-|±/?|< 30|Routine screening|
|-|+|> 30|Repeat screening in 1 year|
|-|-/?|> 30|Routine screening|
|ASC-US|+/?|< 25|Repeat screening in 1 year|
|ASC-US|-|< 25|Routine screening|
|ASC-US|?|> 25|Repeat screening in 1 year|
|ASC-US|-|> 25|Repeat screening in 3 years|
|LSIL|±/?|< 25|Repeat screening in 1 year|
|LSIL|-|> 25|Repeat screening in 1 year|
|Consecutive<br>Otherwise|±/?|Any|Colposcopy ± LEEP|

## Treatment of Cervical Intraepithelial Neoplasia (CIN)

|CIN|Treatment|
|-|-|
|I|Repeat screening in 1 year|
|II<br>III|Loop electrosurgical excision procedure (LEEP)<br>Conization<br>Cryotherapy<br>Laser ablation|

## Reference Limits of Semen Analysis

- Volume > 1.5 mL
- Sperm concentration > 15 M/mL
- Total sperm count > 39 M
- Normal forms > 4%
- Vitality > 58%
- Progressive motility > 32%
- Total motility > 40%

## Indications of Assisted Reproductive Technology (ART)

### Intrauterine Insemination (IUI)

- Cervical factors
- Male factors
- Donor sperms

### In Vitro Fertilization (IVF)

- Tubal factors
- Donor eggs
- Genetic screening
- Failed intrauterine insemination (IUI)

## Controlled Ovarian Hyperstimulation

### Suppression of Spontaneous Ovulation

|Protocol|Timing|
|-|-|
|GnRH agonist long protocol|Last luteal phase|
|GnRH agonist short protocol|Menstruation|
|GnRH antagonist protocol|Leading follicle > 14 mm|

### Ovulation Induction

- (Follicles > 18 mm) ≥ 2
- Estradiol per co-dominant follicle > 200 pg/mL

|Mechanism|Medication|
|-|-|-|
|GnRH agonists|Leuprolide :: pulsatile|
|hCG agonists|Choriogonadotropin|

![](../Figures/Controlled%20Ovarian%20Hyperstimulation.png)

## Breast Imaging Reporting and Data System (BI-RADS)

|Category|Interpretation|Management|Likelihood of cancer|
|-|-|-|-|
|0|Inconclusive|Repeat|-|
|1|Negative|Routine|0|
|2|Benign|Routine|0|
|3|Probably benign|Every 6 months|< 2%|
|4|Suspicious|Biopsy|2 ~ 95%|
|5|Highly suggestive|Biopsy|> 95%|
|6|Biopsy-proven|-|-|

## Breast Tumors

### Epithelial Tumors

- Fibrocystic change
- Intraductal papilloma
- Ductal carcinoma in situ (DCIS)<br>Invasive ductal carcinoma (IDC)
- Lobular carcinoma in situ (LCIS)<br>Invasive lobular carcinoma (ILC)
- Medullary carcinoma

### Stromal Tumors

- Fibroadenoma
- Phyllodes tumor

![](../Figures/Breast%20Tumors.png)

## Molecular Subtypes of Breast Cancer

|Subtype|Receptors|Mutations|
|-|-|
|Luminal A|PR & ER|-|
|Luminal B|PR & ER|-|
|HER2-enriched|HER2|-|
|Basal-like|-|BRCA|
|Claudin-low|-|BRCA|
|Interferon-rich|-|BRCA|

![](../Figures/Breast%20Cancer%20>%20Molecular%20Subtypes.png)

## Types of Flaps for Breast Reconstruction

- Transverse rectus abdominis myocutaneous (TRAM) flap
- Latissimus dorsi (LD) flap
- Deep inferior epigastric perforator (DIEP) flap
- Superficial inferior epigastric artery (SIEA) flap
- Gluteal flap
- Transverse upper gracilis (TUG) flap
- Profunda artery perforator (PAP) flap
